Drug interaction and chronic obstructive respiratory disorders
Chronic obstructive respiratory disorders uncontrolled by monotherapy should be given combinations of drugs that act by distinct mechanisms of action. The rationale for combining different classes of drugs should be to elicit a synergistic interaction, lower the dose of the single components in the...
Saved in:
Main Authors: | Paola Rogliani (Author), Beatrice Ludovica Ritondo (Author), Bartolomeo Zerillo (Author), Maria Gabriella Matera (Author), Luigino Calzetta (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022) -
Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration
by: Beatrice Ludovica Ritondo, et al.
Published: (2021) -
Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences
by: Mario Cazzola, et al.
Published: (2023) -
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis
by: Luigino Calzetta, et al.
Published: (2022) -
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement
by: Luigino Calzetta, et al.
Published: (2024)